These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18183009)

  • 21. Biotechnology's foreign policy.
    Feldbaum C
    World Hosp Health Serv; 2002; 38(2):42-5. PubMed ID: 12402751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chile launches policy to boost biotech.
    Orellana C
    Nat Biotechnol; 2004 Jan; 22(1):7-8. PubMed ID: 14704689
    [No Abstract]   [Full Text] [Related]  

  • 23. Enabling Europe to innovate.
    Dearing A
    Science; 2007 Jan; 315(5810):344-7. PubMed ID: 17234939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The myth of the biotech revolution.
    Nightingale P; Martin P
    Trends Biotechnol; 2004 Nov; 22(11):564-9. PubMed ID: 15491800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Euro biotech report adds to paper mountain.
    Hodgson J
    Nat Biotechnol; 2001 May; 19(5):397-8. PubMed ID: 11328984
    [No Abstract]   [Full Text] [Related]  

  • 26. It isn't yours: campaigners call for a ban on all genetic patents.
    Pearce F
    New Sci; 2002 Feb; 173(2329):15. PubMed ID: 12374167
    [No Abstract]   [Full Text] [Related]  

  • 27. Biotech sector ponders potential 'bloodbath'.
    Mitchell P
    Nat Biotechnol; 2009 Jan; 27(1):3-4. PubMed ID: 19131974
    [No Abstract]   [Full Text] [Related]  

  • 28. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 30. Profiles of four top biotech companies in India.
    Suresh N; Rao ChS
    Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
    [No Abstract]   [Full Text] [Related]  

  • 31. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

  • 32. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotech industry woos MEPs to ease regulatory burden.
    Abbott A
    Nature; 1996 Apr; 380(6576):656. PubMed ID: 8614445
    [No Abstract]   [Full Text] [Related]  

  • 34. China moves to reform biotech policies.
    Jia H
    Nat Biotechnol; 2004 Oct; 22(10):1197. PubMed ID: 15470442
    [No Abstract]   [Full Text] [Related]  

  • 35. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 36. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilski blundering biotech.
    Simmons WJ
    Nat Biotechnol; 2009 Mar; 27(3):245-8. PubMed ID: 19270670
    [No Abstract]   [Full Text] [Related]  

  • 38. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 39. Biotech patents still strong.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1341. PubMed ID: 18066014
    [No Abstract]   [Full Text] [Related]  

  • 40. Say no to stem cell patents: Europe advised to take a different stance to the US.
    Coghlan A
    New Sci; 2002 May; 174(2343):5. PubMed ID: 12731533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.